| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |